Jeffrey Laurence1, Sonia Elhadad1, Sandra Gostynska2, Zhongxin Yu3, Hunter Terry1, Rohan Varshney2, Kar-Ming Fung3, Mary E Choi4, Jasimuddin Ahamed2. 1. Division of Hematology and Medical Oncology. 2. Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation (OMRF), Oklahoma City, Oklahoma, USA. 3. Department of Pathology, University of Oklahoma Health Sciences Center. 4. Division of Nephrology and Hypertension, Weill Cornell Medical College (WCMC), New York, New York.
Abstract
OBJECTIVE: Chronic kidney disease (CKD) with tubular injury and fibrosis occurs in HIV infection treated with certain protease inhibitor-based antiretroviral therapies. The pathophysiology is unclear. DESIGN: We hypothesized that fibrosis, mediated by platelet-derived transforming growth factor (TGF)-β1, underlies protease inhibitor-associated CKD. We induced this in mice exposed to the protease inhibitor ritonavir (RTV), and intervened with low-dose inhaled carbon monoxide (CO), activating erythroid 2-related factor (Nrf2)-associated antioxidant pathways. METHODS: Wild-type C57BL/6 mice and mice deficient in platelet TGF-β1, were given RTV (10 mg/kg) or vehicle daily for 8 weeks. Select groups were exposed to CO (250 ppm) for 4 h after RTV or vehicle injection. Renal disorder, fibrosis, and TGF-β1-based and Nrf2-based signaling were examined by histology, immunofluorescence, and flow cytometry. Renal damage and dysfunction were assessed by KIM-1 and cystatin C ELISAs. Clinical correlations were sought among HIV-infected individuals. RESULTS: RTV-induced glomerular and tubular injury, elevating urinary KIM-1 (P = 0.004). It enhanced TGF-β1-related signaling, accompanied by kidney fibrosis, macrophage polarization to an inflammatory phenotype, and renal dysfunction with cystatin C elevation (P = 0.008). Mice lacking TGF-β1 in platelets were partially protected from these abnormalities. CO inhibited RTV-induced fibrosis and macrophage polarization in association with upregulation of Nrf2 and heme oxygenase-1 (HO-1). Clinically, HIV infection correlated with elevated cystatin C levels in untreated women (n = 17) vs. age-matched controls (n = 19; P = 0.014). RTV-treated HIV+ women had further increases in cystatin C (n = 20; P = 0.05), with parallel elevation of HO-1. CONCLUSION: Platelet TGF-β1 contributes to RTV-induced kidney fibrosis and dysfunction, which may be amenable to antioxidant interventions.
OBJECTIVE: Chronic kidney disease (CKD) with tubular injury and fibrosis occurs in HIV infection treated with certain protease inhibitor-based antiretroviral therapies. The pathophysiology is unclear. DESIGN: We hypothesized that fibrosis, mediated by platelet-derived transforming growth factor (TGF)-β1, underlies protease inhibitor-associated CKD. We induced this in mice exposed to the protease inhibitor ritonavir (RTV), and intervened with low-dose inhaled carbon monoxide (CO), activating erythroid 2-related factor (Nrf2)-associated antioxidant pathways. METHODS: Wild-type C57BL/6 mice and mice deficient in platelet TGF-β1, were given RTV (10 mg/kg) or vehicle daily for 8 weeks. Select groups were exposed to CO (250 ppm) for 4 h after RTV or vehicle injection. Renal disorder, fibrosis, and TGF-β1-based and Nrf2-based signaling were examined by histology, immunofluorescence, and flow cytometry. Renal damage and dysfunction were assessed by KIM-1 and cystatin C ELISAs. Clinical correlations were sought among HIV-infected individuals. RESULTS: RTV-induced glomerular and tubular injury, elevating urinary KIM-1 (P = 0.004). It enhanced TGF-β1-related signaling, accompanied by kidney fibrosis, macrophage polarization to an inflammatory phenotype, and renal dysfunction with cystatin C elevation (P = 0.008). Mice lacking TGF-β1 in platelets were partially protected from these abnormalities. CO inhibited RTV-induced fibrosis and macrophage polarization in association with upregulation of Nrf2 and heme oxygenase-1 (HO-1). Clinically, HIV infection correlated with elevated cystatin C levels in untreated women (n = 17) vs. age-matched controls (n = 19; P = 0.014). RTV-treated HIV+ women had further increases in cystatin C (n = 20; P = 0.05), with parallel elevation of HO-1. CONCLUSION: Platelet TGF-β1 contributes to RTV-induced kidney fibrosis and dysfunction, which may be amenable to antioxidant interventions.
Authors: Charles D Mitchell; Miriam C Chernoff; George R Seage; Murli U Purswani; Hans M L Spiegel; Gaston Zilleruelo; Carolyn Abitbol; Barbara Heckman; Christopher B Ponce; James M Oleske Journal: Pediatr Nephrol Date: 2014-08-24 Impact factor: 3.714
Authors: Edgar Turner Overton; Pragna Patel; Kristin Mondy; Tim Bush; Lois Conley; Frank Rhame; Erna Milunka Kojic; John Hammer; Keith Henry; John T Brooks Journal: AIDS Res Hum Retroviruses Date: 2011-05-25 Impact factor: 2.205
Authors: Kirk A Taylor; Erica Smyth; Francesca Rauzi; Maddalena Cerrone; Akif A Khawaja; Brian Gazzard; Mark Nelson; Marta Boffito; Michael Emerson Journal: Br J Pharmacol Date: 2019-03-14 Impact factor: 8.739
Authors: Junyu Lu; Qi Cao; Dong Zheng; Yan Sun; Changqi Wang; Xiao Yu; Ya Wang; Vincent W S Lee; Guoping Zheng; Thian K Tan; Xin Wang; Stephen I Alexander; David C H Harris; Yiping Wang Journal: Kidney Int Date: 2013-05-01 Impact factor: 10.612
Authors: Alexander Meyer; Wei Wang; Jiaxiang Qu; Lori Croft; Jay L Degen; Barry S Coller; Jasimuddin Ahamed Journal: Blood Date: 2011-12-01 Impact factor: 25.476
Authors: Todd Hulgan; M Sean Boger; Diana H Liao; Grace A McComsey; Christine A Wanke; Alexandra Mangili; Sharon L Walmsley; Heather McCreath; Ginger L Milne; Stephanie C Sanchez; Judith S Currier; Jordan E Lake Journal: Mediators Inflamm Date: 2014-06-01 Impact factor: 4.711
Authors: Eve-Irene Lepist; Xuexiang Zhang; Jia Hao; Jane Huang; Alan Kosaka; Gabriel Birkus; Bernard P Murray; Roy Bannister; Tomas Cihlar; Yong Huang; Adrian S Ray Journal: Kidney Int Date: 2014-03-19 Impact factor: 10.612